Impact of Butylphthalide and Atorvastatin on Acute Cerebral Infarction
Study Overview
Acute cerebral infarction is a serious health issue, and finding effective treatments is essential. This study evaluated how combining Butylphthalide and Atorvastatin affects neurological function, quality of life, and blood vessel health in 124 patients with acute cerebral infarction.
Key Findings
Participants were divided into two groups: a control group and an experimental group that received the combination therapy. The experimental group showed significant improvements in:
- Neurological function
- Quality of life
- Vascular endothelial function
These improvements were measured using established scales and biochemical markers, indicating that this drug combination can effectively manage acute cerebral infarction.
Clinical Implications
This study highlights the potential benefits of using Butylphthalide and Atorvastatin together in treating acute cerebral infarction.
Enhancing Clinical Practice with Technology
Importance of Clinical Trials
Clinical trials are essential for developing safe and effective treatments. It’s vital to integrate their findings into everyday medical practice.
DocSym: A Solution for Clinicians
Our AI-driven platform, DocSym, simplifies access to ICD-11 standards, clinical protocols, and research. This makes it easier for healthcare providers to stay informed and improve patient care.
Streamlining Healthcare Operations
In today’s healthcare landscape, efficiency is key. Our mobile apps facilitate:
- Scheduling appointments
- Monitoring treatments
- Telemedicine services
This helps clinics manage patient care more effectively and expand their digital services.
Improving Patient Outcomes
By leveraging AI, clinics can enhance workflows, improve patient outcomes, and reduce reliance on paper processes. Discover more about our solutions at aidevmd.com.
